Jamjoom Pharmaceuticals Factory Co.

Jamjoom Pharmaceuticals Factory Co. is a Saudi Arabian manufacturer of specialty and generic pharmaceutical products. The company develops, produces, and markets a wide range of medicines, including branded generics, over-the-counter (OTC) drugs, and specialty pharmaceuticals. Founded in 1991 and headquartered in Jeddah, Jamjoom Pharma operates state-of-the-art manufacturing facilities that comply with international quality standards such as Good Manufacturing Practices (GMP). Its product portfolio spans therapeutic areas like cardiology, gastroenterology, neurology, and respiratory care, among others.

The company generates revenue primarily through the sale of pharmaceutical products to wholesalers, hospitals, pharmacies, and government healthcare institutions. Its business model focuses on research and development of generic equivalents to branded drugs, as well as in-licensing and co-marketing agreements with international pharmaceutical firms. The recent quarters show strong revenue growth of 85.36% year-over-year, driven by new product launches and expanded market penetration. With minimal debt (20.77M SAR) and substantial cash reserves (206.08M SAR), Jamjoom maintains a healthy balance sheet.

Jamjoom Pharma operates in the highly regulated pharmaceutical industry within the healthcare sector. It competes with other local and regional generic drug manufacturers, as well as multinational companies. The company's competitive advantages include its strong brand recognition in Saudi Arabia, a diversified product portfolio, and a robust distribution network. Its high gross margin of 62.22% and operating margin of 32.33% indicate efficient operations and pricing power. The company is positioned as a leading player in the Saudi generic pharmaceutical market, benefiting from government initiatives to localize drug production.

The company's primary customers are healthcare providers, including hospitals, clinics, and pharmacies, as well as government health agencies. Its target audience includes patients seeking affordable generic alternatives to branded medications. Geographically, Jamjoom Pharma focuses on the Saudi Arabian market, which accounts for the vast majority of its revenue. However, it also exports to other Middle Eastern and North African countries. The company's growth strategy includes expanding its product portfolio and increasing its presence in regional markets.

An auto-generated descriptive profile based on company data, for informational purposes only.